RxSight, Inc. (RXST) Tops Q1 EPS by 22c

RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.31), $0.22 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.28 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)